MicroRNAs Indirectly Regulate Other MicroRNAs in Ovarian Cancer Cells

References (83)

1. 1 MicroRNAs [DOI]
2. 2 MicroRNA signatures in human cancers [DOI]
3. 3 Oncomirs — microRNAs with a role in cancer [DOI]
4. 4 Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs [DOI]
5. 5 The widespread regulation of microRNA biogenesis, function and decay [DOI]
6. 6 Human MicroRNA Targets [DOI]
7. 7 The impact of microRNAs on protein output [DOI]
8. 8 A microRNA polycistron as a potential human oncogene [DOI]
9. 9 Widespread changes in protein synthesis induced by microRNAs [DOI]
10. 10 NF-κB: linking inflammation and immunity to cancer development and progression [DOI]
11. 11 The microRNA.org resource: targets and expression [DOI]
12. 12 Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis [DOI]
13. 13 Endogenous human microRNAs that suppress breast cancer metastasis [DOI]
14. 14 Non–coding RNA genes and the modern RNA world [DOI]
15. 15 MicroRNA-373 induces expression of genes with complementary promoter sequences [DOI]
16. 16 Characterization of microRNA expression profiles in normal human tissues [DOI]
17. 17 MicroRNAs: Synthesis, mechanism, function, and recent clinical trials [DOI]
18. 18 Comprehensive proteomic analysis of the human spliceosome [DOI]
19. 19 miRNAs in human cancer [DOI]
20. 20 MicroRNA-directed transcriptional gene silencing in mammalian cells [DOI]
21. 21 Genomic analysis of human microRNA transcripts [DOI]
22. 22 A Parsimonious Model for Gene Regulation by miRNAs [DOI]
23. 23 Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7 [DOI]
24. 24 MiRNAs and Cancer [DOI]
25. 25 The role of microRNAs in cancer: No small matter [DOI]
26. 26 MicroRNA-9 Regulates Neurogenesis in Mouse Telencephalon by Targeting Multiple Transcription Factors [DOI]
27. 27 MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer [DOI]
28. 28 Transcriptional suppression of mir‐29b‐1/mir‐29a promoter by c‐Myc, hedgehog, and NF‐kappaB [DOI]
29. 29 Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers [DOI]
30. 30 Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries [DOI]
31. 31 NF-kappaB p65-Dependent Transactivation of miRNA Genes following Cryptosporidium parvum Infection Stimulates Epithelial Cell Immune Responses [DOI]
32. 32 MiRNA expression in urothelial carcinomas: Important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31 [DOI]
33. 33 MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells [DOI]
34. 34 Peptide-Functionalized Nanogels for Targeted siRNA Delivery [DOI]
35. 35 Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion [DOI]
36. 36 Identification of cardiomyocyte nuclei and assessment of ploidy for the analysis of cell turnover [DOI]
37. 37 Reduced microRNA‐218 expression is associated with high nuclear factor kappa B activation in gastric cancer [DOI]
38. 38 Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells [DOI]
39. 39 Chemosensitization of cancer cells by siRNA using targeted nanogel delivery [DOI]
40. 40 Nuclear Factor-κB Contributes to Anaplastic Thyroid Carcinomas through Up-Regulation of miR-146a [DOI]
41. 41 A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro [DOI]
42. 42 Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets [DOI]
43. 43 Extracellular matrix production by adipose-derived stem cells: Implications for heart valve tissue engineering [DOI]
44. 44 Evidence for the Complexity of MicroRNA-Mediated Regulation in Ovarian Cancer: A Systems Approach [DOI]
45. 45 The art of microRNA: Various strategies leading to gene silencing via an ancient pathway [DOI]
46. 46 Effect of tissue fixatives on telomere length determination by quantitative PCR [DOI]
47. 47 Purification and Characterization [DOI]
48. 48 Chromatin structure analyses identify miRNA promoters [DOI]
49. 49 Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. [DOI]
50. 50 Gene silencing in mammalian cells [DOI]
51. 51 Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR [DOI]
52. 52 Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project [DOI]
53. 53 Mammalian microRNAs predominantly act to decrease target mRNA levels [DOI]
54. 54 MicroRNA targets in Drosophila [DOI]
55. 55 Regulation of mRNA Translation and Stability by microRNAs [DOI]
56. 56 MicroRNAs in Cancer [DOI]
57. 57 Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes [DOI]
58. 58 Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes [DOI]
59. 59 Genomics of microRNA [DOI]
60. 60 microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma [DOI]
61. 61 Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 [DOI]
62. 62 Structure and activity of putative intronic miRNA promoters [DOI]
63. 63 Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer [DOI]
64. 64 Role of MicroRNA-155 at Early Stages of Hepatocarcinogenesis Induced by Choline-Deficient and Amino Acid–Defined Diet in C57BL/6 Mice† [DOI]
65. 65 microRNAs: Master Regulators as Potential Therapeutics in Cancer [DOI]
66. 66 MicroRNA-7, a Homeobox D10 Target, Inhibits p21-Activated Kinase 1 and Regulates Its Functions [DOI]
67. 67 EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF [DOI]
68. 68 A new paradigm for developmental biology [DOI]
69. 69 A Splicing-Independent Function of SF2/ASF in MicroRNA Processing [DOI]
70. 70 miRNA-7 Attenuation in Schwannoma Tumors Stimulates Growth by Upregulating Three Oncogenic Signaling Pathways [DOI]
71. 71 Human Ago2 Is Required for Efficient MicroRNA 122 Regulation of Hepatitis C Virus RNA Accumulation and Translation [DOI]
72. 72 Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma [DOI]
73. 73 Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates [DOI]
74. 74 Complementary miRNA pairs suggest a regulatory role for miRNA:miRNA duplexes: FIGURE 1. [DOI]
75. 75 Consensus miRNA expression profiles derived from interplatform normalization of microarray data [DOI]
76. 76 Epidermal Growth Factor Receptor Variant III–Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression [DOI]
77. 77 Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: Lower levels of CYP1B1 and increased expression of S-COMT [DOI]
78. 78 Regulated expression of microRNAs-126/126* inhibits erythropoiesis from human embryonic stem cells [DOI]
79. 79 Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network [DOI]
80. 80 Probe set filtering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements [DOI]
81. 81 Gold glitters everywhere: nucleus microRNAs and their functions [DOI]
82. 82 Identification of Mammalian microRNA Host Genes and Transcription Units [DOI]
83. 83 Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts [DOI]

Cited by 8

Showing 4 of 8 known citations — external sources report more than can currently be individually listed.

Related research

• Diagnostic Role of Aberrant DNA Promoter Methylation in Ovarian Cancer — shares topic coverage
• Role of Human Beta Defensin-2 and Oxidative Stress Parameters in Ovarian Cancer Patients — shares topic coverage
• A Review on the Evolutionary Trajectories of mRNA BRCA1/2 Genes in Primates and the Implications of Cancer Susceptibility Variants within Immediate Human Populations — shares topic coverage
• Expression of ERα, its ERαΔ3 Splice Variant and γ-SYNUCLEIN in Ovarian Cancer: A Pilot Study — shares topic coverage
• Impact of Hormonal Status on Outcome of Aromatase Inhibitor Maintenance Post-adjuvant Chemotherapy in High Grade Serous Ovarian Cancer (HGSOC): A Phase II Study — shares topic coverage